The terms "we," "us," "our," "Daré" or the "Company" refer collectively to Daré
Bioscience, Inc. and its wholly-owned subsidiaries, unless otherwise stated or
the context otherwise requires. All information presented in this report is
based on our fiscal year. Unless otherwise stated, references to particular
years, quarters, months or periods refer to our fiscal years ending December 31
and the associated quarters, months and periods of those fiscal years.
Overview
We are a clinical-stage biopharmaceutical company committed to the advancement
of innovative products for women's reproductive health. We are driven by a
mission to identify, develop and bring to market a diverse portfolio of
differentiated therapies that expand treatment options, improve outcomes and
facilitate convenience for women, primarily in the areas of contraception,
vaginal health, sexual health and fertility.